• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Prothena Corp (NQ: PRTA )

    17.58 -0.50 (-2.77%)
    Streaming Delayed Price Updated: 3:44 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Prothena Corp

    < Previous 1 2 3 4 5 6 7 Next >
    PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Breaking Down Prothena Corp: 4 Analysts Share Their Views
    Via Benzinga
    Dow Dips 300 Points; Emcore Shares Spike Higher
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Crude Oil Moves Higher; Prime Medicine Shares Spike Higher
    Via Benzinga
    Exposures Fossil Fuels
    Demystifying Prothena Corp: Insights From 8 Analyst Reviews
    Via Benzinga
    Decoding 6 Analyst Evaluations For Prothena Corp
    Via Benzinga
    Prothena Corp: Q4 Earnings Insights
    Via Benzinga
    Prothena Announces Leadership Team Updates
    From Prothena Corporation plc
    Via Business Wire
    Prothena to Participate in Upcoming Healthcare Conferences
    From Prothena Corporation plc
    Via Business Wire
    PRTA Stock Earnings: Prothena Corp Beats EPS, Beats Revenue for Q2 2024
    PRTA stock results show that Prothena Corp beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Prothena Reports Second Quarter 2024 Financial Results and Business Highlights
    From Prothena Corporation plc
    Via Business Wire
    Earnings Scheduled For February 15, 2024
    Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million. 
    Via Benzinga
    Earnings Outlook For Prothena Corp
    Via Benzinga
    Navigating 5 Analyst Ratings For Prothena Corp
    Via Benzinga
    Prothena to Report Second Quarter 2024 Financial Results on August 8
    From Prothena Corporation plc
    Via Business Wire
    Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win
    An FDA panel unanimously backed Eli Lilly's Alzheimer's drug, but shares of Lilly and its rivals fell Tuesday. 
    Via Investor's Business Daily
    Exposures Product Safety
    Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration
    From Prothena Corporation plc
    Via Business Wire
    PRTA Stock Earnings: Prothena Corp Misses EPS, Misses Revenue for Q1 2024
    PRTA stock results show that Prothena Corp missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Prothena Reports First Quarter 2024 Financial Results and Business Highlights
    From Prothena Corporation plc
    Via Business Wire
    Prothena to Report First Quarter 2024 Financial Results on May 8
    From Prothena Corporation plc
    Via Business Wire
    Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
    From Prothena Corporation plc
    Via Business Wire
    Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
    The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting. 
    Via Investor's Business Daily
    Exposures Product Safety
    Prothena to Participate in Upcoming Healthcare Conferences
    From Prothena Corporation plc
    Via Business Wire
    Prothena Appoints David Ford to Newly Created Chief People Officer Position
    From Prothena Corporation plc
    Via Business Wire
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate
    From Prothena Corporation plc
    Via Business Wire
    Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights
    From Prothena Corporation plc
    Via Business Wire
    Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
    From Prothena Corporation plc
    Via Business Wire
    Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.